IDEAS home Printed from https://ideas.repec.org/f/c/pke384.html
   My authors  Follow this author

Jonathan D. Ketcham

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Wikipedia or ReplicationWiki mentions

(Only mentions on Wikipedia that link back to a page on a RePEc service)
  1. Jonathan D. Ketcham & Nicolai V. Kuminoff & Christopher A. Powers, 2016. "Choice Inconsistencies among the Elderly: Evidence from Plan Choice in the Medicare Part D Program: Comment," American Economic Review, American Economic Association, vol. 106(12), pages 3932-3961, December.

    Mentioned in:

    1. Choice Inconsistencies among the Elderly: Evidence from Plan Choice in the Medicare Part D Program: Comment (AER 2016) in ReplicationWiki ()
  2. Jonathan D. Ketcham & Claudio Lucarelli & Eugenio J. Miravete & M. Christopher Roebuck, 2012. "Sinking, Swimming, or Learning to Swim in Medicare Part D," American Economic Review, American Economic Association, vol. 102(6), pages 2639-2673, October.

    Mentioned in:

    1. Sinking, Swimming, or Learning to Swim in Medicare Part D (AER 2006) in ReplicationWiki ()

Working papers

  1. Michael P. Keane & Jonathan D. Ketcham & Nicolai V. Kuminoff & Timothy Neal, 2019. "Evaluating Consumers' Choices of Medicare Part D Plans: A Study in Behavioral Welfare Economics," NBER Working Papers 25652, National Bureau of Economic Research, Inc.

    Cited by:

    1. Shuo Zhang & Tat Y. Chan & Xueming Luo & Xiaoyi Wang, 2022. "Time-Inconsistent Preferences and Strategic Self-Control in Digital Content Consumption," Marketing Science, INFORMS, vol. 41(3), pages 616-636, May.

  2. Kelly C. Bishop & Jonathan D. Ketcham & Nicolai V. Kuminoff, 2018. "Hazed and Confused: The Effect of Air Pollution on Dementia," NBER Working Papers 24970, National Bureau of Economic Research, Inc.

    Cited by:

    1. Catherine Hausman & Samuel Stolper, 2020. "Inequality, Information Failures, and Air Pollution," NBER Working Papers 26682, National Bureau of Economic Research, Inc.
    2. Persico, Claudia L. & Johnson, Kathryn R., 2020. "Deregulation in a Time of Pandemic: Does Pollution Increase Coronavirus Cases or Deaths?," IZA Discussion Papers 13231, Institute of Labor Economics (IZA).
    3. Stepan Mikula & Mariola Pytlikova, 2021. "Air Pollution and Migration: Exploiting a Natural Experiment from the Czech Republic," CERGE-EI Working Papers wp714, The Center for Economic Research and Graduate Education - Economics Institute, Prague.
    4. Fu, Shihe & Viard, V. Brian, 2021. "A Mayor’s Perspective on Tackling Air Pollution," MPRA Paper 107434, University Library of Munich, Germany.
    5. Jonathan Colmer & Dajun Lin & Siying Liu & Jay Shimshack, 2020. "Why are pollution damages lower in developed countries? Insights from high income, high-particulate matter Hong Kong," CEP Discussion Papers dp1702, Centre for Economic Performance, LSE.
    6. Štěpán Mikula & Mariola Pytliková, 2020. "Air Pollution & Migration: Exploiting a Natural Experiment from the Czech Republic," EconPol Working Paper 43, ifo Institute - Leibniz Institute for Economic Research at the University of Munich.
    7. Stephanie von Hinke & Emil Sorensen, 2022. "The Long-Term Effects of Early-Life Pollution Exposure: Evidence from the London Smog," Bristol Economics Discussion Papers 22/757, School of Economics, University of Bristol, UK.
    8. Margaryan, Shushanik, 2021. "Low emission zones and population health," Journal of Health Economics, Elsevier, vol. 76(C).
    9. Diane Alexander & Hannes Schwandt, 2022. "The Impact of Car Pollution on Infant and Child Health: Evidence from Emissions Cheating [Management and Shocks to Worker Productivity]," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 89(6), pages 2872-2910.
    10. Jill Furzer & Boriana Miloucheva, 2020. "The Long Arm of the Clean Air Act: Pollution Abatement and COVID-19 Racial Disparities," Working Papers tecipa-668, University of Toronto, Department of Economics.
    11. Ordoñez, Pablo J., 2020. "Power Plants, Air Pollution, and Health in Colombia," 2020 Annual Meeting, July 26-28, Kansas City, Missouri 304284, Agricultural and Applied Economics Association.
    12. Burkhardt, Jesse & Bayham, Jude & Wilson, Ander & Carter, Ellison & Berman, Jesse D. & O'Dell, Katelyn & Ford, Bonne & Fischer, Emily V. & Pierce, Jeffrey R., 2019. "The effect of pollution on crime: Evidence from data on particulate matter and ozone," Journal of Environmental Economics and Management, Elsevier, vol. 98(C).
    13. Hui Deng & Rui Du & Dongmei Guo & Weizeng Sun & Yuhuan Xia, 2023. "High‐stakes examinations and educational inequality: Evidence from transitory exposure to air pollution," Economic Inquiry, Western Economic Association International, vol. 61(3), pages 546-571, July.
    14. Sager, Lutz & Singer, Gregor, 2023. "Clean identification? The effects of the Clean Air Act on air pollution, exposure disparities and house prices," LSE Research Online Documents on Economics 115528, London School of Economics and Political Science, LSE Library.
    15. Zhenyu Yao & Wei Zhang & Xinde Ji & Weizhe Weng, 2023. "Short-Term Exposure to Air Pollution and Cognitive Performance: New Evidence from China’s College English Test," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 85(1), pages 211-237, May.
    16. Liu, Pihui & Han, Chuanfeng & Teng, Minmin, 2022. "Does clean cooking energy improve mental health? Evidence from China," Energy Policy, Elsevier, vol. 166(C).
    17. Qi He & Xinde (James) Ji, 2021. "The Labor Productivity Consequences of Exposure to Particulate Matters: Evidence from a Chinese National Panel Survey," IJERPH, MDPI, vol. 18(23), pages 1-22, December.
    18. Huang, Jialin & Xing, Jianwei & Yongchen Zou, Eric, 2023. "(Re)scheduling pollution exposure: The case of surgery schedules," Journal of Public Economics, Elsevier, vol. 219(C).
    19. Leroutier, Marion & Quirion, Philippe, 2022. "Air pollution and CO2 from daily mobility: Who emits and Why? Evidence from Paris," Energy Economics, Elsevier, vol. 109(C).
    20. Wang, Xiqian & Bian, Yong & Zhang, Qin, 2023. "The effect of cooking fuel choice on the elderly’s well-being: Evidence from two non-parametric methods," Energy Economics, Elsevier, vol. 125(C).
    21. Dube, Benjamin, 2021. "Why cross and mix disciplines and methodologies?: Multiple meanings of Interdisciplinarity and pluralism in ecological economics," Ecological Economics, Elsevier, vol. 179(C).
    22. Kenneth Gillingham & Pei Huang, 2021. "Racial Disparities in the Health Effects from Air Pollution: Evidence from Ports," NBER Working Papers 29108, National Bureau of Economic Research, Inc.
    23. Zivin, Joshua Graff & Singer, Gregor, 2023. "Disparities in pollution capitalization rates: the role of direct and systemic discrimination," LSE Research Online Documents on Economics 118093, London School of Economics and Political Science, LSE Library.
    24. Felix Holub & Laura Hospido & Ulrich J. Wagner, 2020. "Urban Air Pollution and Sick Leaves: Evidence From Social Security Data," CRC TR 224 Discussion Paper Series crctr224_2020_241, University of Bonn and University of Mannheim, Germany.
    25. Andrea La Nauze & Edson R. Severnini, 2021. "Air Pollution and Adult Cognition: Evidence from Brain Training," NBER Working Papers 28785, National Bureau of Economic Research, Inc.
    26. Austin, Wes & Carattini, Stefano & Gomez-Mahecha, John & Pesko, Michael F., 2023. "The effects of contemporaneous air pollution on COVID-19 morbidity and mortality," Journal of Environmental Economics and Management, Elsevier, vol. 119(C).
    27. Janet Currie & Reed Walker, 2019. "What Do Economists Have to Say about the Clean Air Act 50 Years after the Establishment of the Environmental Protection Agency?," Journal of Economic Perspectives, American Economic Association, vol. 33(4), pages 3-26, Fall.
    28. Marion Leroutier & Philippe Quirion, 2021. "Tackling Transport-Induced Pollution in Cities: A case Study in Paris," Working Papers 2021.07, FAERE - French Association of Environmental and Resource Economists.
    29. Wangyang Lai & Shanjun Li & Yanan Li & Xiaohui Tian, 2022. "Air Pollution and Cognitive Functions: Evidence from Straw Burning in China," American Journal of Agricultural Economics, John Wiley & Sons, vol. 104(1), pages 190-208, January.
    30. Wes Austin & Stefano Carattini & John Gomez Mahecha & Michael Pesko, 2020. "Covid-19 Mortality and Contemporaneous Air Pollution," CESifo Working Paper Series 8609, CESifo.
    31. Luis Sarmiento, 2022. "Air pollution and the productivity of high‐skill labor: evidence from court hearings," Scandinavian Journal of Economics, Wiley Blackwell, vol. 124(1), pages 301-332, January.

  3. Jonathan D. Ketcham & Nicolai V. Kuminoff & Christopher A. Powers, 2016. "Estimating the Heterogeneous Welfare Effects of Choice Architecture: An Application to the Medicare Prescription Drug Insurance Market," NBER Working Papers 22732, National Bureau of Economic Research, Inc.

    Cited by:

    1. Sebastien Houde & Erica Myers, 2019. "Heterogeneous (Mis-) Perceptions of Energy Costs: Implications for Measurement and Policy Design," CER-ETH Economics working paper series 19/314, CER-ETH - Center of Economic Research (CER-ETH) at ETH Zurich.
    2. Nicolai V. Kuminoff, 2018. "Can Understanding Spatial Equilibria Enhance Benefit Transfers for Environmental Policy Evaluation?," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 69(3), pages 591-608, March.
    3. Donald S. Kenkel & Sida Peng & Michael F. Pesko & Hua Wang, 2020. "Mostly harmless regulation? Electronic cigarettes, public policy, and consumer welfare," Health Economics, John Wiley & Sons, Ltd., vol. 29(11), pages 1364-1377, November.
    4. Cornel Kaufmann & Tobias Mueller & Andreas Hefti & Stefan Boes, 2018. "Does personalized information improve health plan choices when individuals are distracted?," Diskussionsschriften dp1808, Universitaet Bern, Departement Volkswirtschaft.
    5. Houde, Sebastien & Aldy, Joseph E., 2017. "The Efficiency Consequences of Heterogeneous Behavioral Responses to Energy Fiscal Policies," Working Paper Series rwp17-047, Harvard University, John F. Kennedy School of Government.
    6. Houde, Sebastien & Aldy, Joseph E., 2017. "The Efficiency Consequences of Heterogeneous Behavioral Responses to Energy Fiscal Policies," RFF Working Paper Series 17-24, Resources for the Future.
    7. Meredith Fowlie & Catherine Wolfram & C. Anna Spurlock & Annika Todd & Patrick Baylis & Peter Cappers, 2017. "Default Effects and Follow-On Behavior: Evidence from an Electricity Pricing Program," NBER Working Papers 23553, National Bureau of Economic Research, Inc.
    8. Jonathan Gruber & Benjamin R. Handel & Samuel H. Kina & Jonathan T. Kolstad, 2020. "Managing Intelligence: Skilled Experts and AI in Markets for Complex Products," NBER Working Papers 27038, National Bureau of Economic Research, Inc.

  4. Jonathan D. Ketcham & Nicolai V. Kuminoff & Christopher A. Powers, 2015. "Which Models Can We Trust to Evaluate Consumer Decision Making? Comment on “Choice Inconsistencies among the Elderly”," NBER Working Papers 21387, National Bureau of Economic Research, Inc.

    Cited by:

    1. Keane, M.P. & Thorp, S., 2016. "Complex Decision Making," Handbook of the Economics of Population Aging, in: Piggott, John & Woodland, Alan (ed.), Handbook of the Economics of Population Aging, edition 1, volume 1, chapter 0, pages 661-709, Elsevier.
    2. Jason Abaluck & Jonathan Gruber, 2015. "The Robustness of Tests for Consumer Choice Inconsistencies," NBER Working Papers 21617, National Bureau of Economic Research, Inc.

  5. Haizhen Lin & Jonathan D. Ketcham & James N. Rosenquest & Kosali Simon, 2013. "Financial Distress and Use of Mental Health Care: Evidence from Antidepressant Prescription Claims," Working Papers 2013-06, Indiana University, Kelley School of Business, Department of Business Economics and Public Policy.

    Cited by:

    1. Katolik, Aleksandra & Oswald, Andrew J., 2017. "Antidepressants for Economists and Business-School Researchers: An Introduction and Review," IZA Discussion Papers 10959, Institute of Labor Economics (IZA).
    2. Ezra Golberstein & Gilbert Gonzales & Ellen Meara, 2019. "How do economic downturns affect the mental health of children? Evidence from the National Health Interview Survey," Health Economics, John Wiley & Sons, Ltd., vol. 28(8), pages 955-970, August.
    3. Alexander C Tsai, 2015. "Home Foreclosure, Health, and Mental Health: A Systematic Review of Individual, Aggregate, and Contextual Associations," PLOS ONE, Public Library of Science, vol. 10(4), pages 1-21, April.
    4. Tomasz Piotr Wisniewski & Brendan John Lambe & Keshab Shrestha, 2020. "Do Stock Market Fluctuations Affect Suicide Rates?," Journal of Financial Research, Southern Finance Association;Southwestern Finance Association, vol. 43(4), pages 737-765, December.
    5. Bénédicte Apouey & Isabelle Chort, 2018. "Are rising house prices really good for your brain? House value and cognitive functioning among older Europeans," Working Papers hal-02141060, HAL.
    6. Katolik, Aleksandra & Oswald, Andrew J., 2017. "Antidepressants for Economists and Business-School Researchers: An Introduction and Review," CAGE Online Working Paper Series 338, Competitive Advantage in the Global Economy (CAGE).
    7. Kárpáti, Daniel & Renneboog, Luc, 2021. "Corporate Financial Frictions and Employee Mental Health," Other publications TiSEM 6ae43003-5b91-4aa8-9621-f, Tilburg University, School of Economics and Management.
    8. Ezra Golberstein & Gilbert Gonzales & Ellen Meara, 2016. "Economic Conditions and Children's Mental Health," NBER Working Papers 22459, National Bureau of Economic Research, Inc.
    9. Preston Morgan & HanNa Lim, 2020. "Depressive Symptom and Financial Conflict Relate Over Time Among Couples," Journal of Family and Economic Issues, Springer, vol. 41(3), pages 391-404, September.
    10. Yilmazer, Tansel & Babiarz, Patryk & Liu, Fen, 2015. "The impact of diminished housing wealth on health in the United States: Evidence from the Great Recession," Social Science & Medicine, Elsevier, vol. 130(C), pages 234-241.
    11. Ayyagari, Padmaja & Shane, Dan M., 2015. "Does prescription drug coverage improve mental health? Evidence from Medicare Part D," Journal of Health Economics, Elsevier, vol. 41(C), pages 46-58.

  6. Miravete, Eugenio & Ketcham, Jonathan D. & Lucarelli, Claudio & Roebuck, M Christopher, 2011. "Sinking, Swimming, or Learning to Swim in Medicare Part D," CEPR Discussion Papers 8585, C.E.P.R. Discussion Papers.

    Cited by:

    1. Sinaiko, Anna & Zeckhauser, Richard, 2016. "Enrollee Choices after Their Health Plans Are Terminated: Default Effects versus Persistent Preferences," Working Paper Series rwp16-055, Harvard University, John F. Kennedy School of Government.
    2. Tal Gross & Timothy J. Layton & Daniel Prinz, 2022. "The Liquidity Sensitivity of Healthcare Consumption: Evidence from Social Security Payments," American Economic Review: Insights, American Economic Association, vol. 4(2), pages 175-190, June.
    3. Barbara Kahn & Alexander Chernev & Ulf Böckenholt & Kate Bundorf & Michaela Draganska & Ryan Hamilton & Robert Meyer & Klaus Wertenbroch, 2014. "Consumer and managerial goals in assortment choice and design," Marketing Letters, Springer, vol. 25(3), pages 293-303, September.
    4. Pilny, Adam & Wübker, Ansgar & Ziebarth, Nicolas R., 2017. "Introducing Risk Adjustment and Free Health Plan Choice in Employer-Based Health Insurance: Evidence from Germany," VfS Annual Conference 2017 (Vienna): Alternative Structures for Money and Banking 168121, Verein für Socialpolitik / German Economic Association.
    5. Scott Morton, Fiona & Ho, Kate & Hogan, Joseph, 2015. "The Impact of Consumer Inattention on Insurer Pricing in the Medicare Part D Program," CEPR Discussion Papers 10976, C.E.P.R. Discussion Papers.
    6. Ali Hortaçsu & Seyed Ali Madanizadeh & Steven L. Puller, 2015. "Power to Choose? An Analysis of Consumer Inertia in the Residential Electricity Market," NBER Working Papers 20988, National Bureau of Economic Research, Inc.
    7. Drake, Coleman & Ryan, Conor & Dowd, Bryan, 2022. "Sources of inertia in the individual health insurance market," Journal of Public Economics, Elsevier, vol. 208(C).
    8. Schumacher, Heiner, 2016. "Insurance, self-control, and contract flexibility," European Economic Review, Elsevier, vol. 83(C), pages 220-232.
    9. Jin, Haofeng, 2022. "The effect of overspending on tariff choices and customer churn: Evidence from mobile plan choices," Journal of Retailing and Consumer Services, Elsevier, vol. 66(C).
    10. Martin Gaynor & Kate Ho & Robert Town, 2014. "The Industrial Organization of Health Care Markets," NBER Working Papers 19800, National Bureau of Economic Research, Inc.
    11. Amanda Starc & Robert J. Town, 2015. "Externalities and Benefit Design in Health Insurance," NBER Working Papers 21783, National Bureau of Economic Research, Inc.
    12. Jeffrey R. Kling & Sendhil Mullainathan & Eldar Shafir & Lee C. Vermeulen & Marian V. Wrobel, "undated". "Comparison Friction: Experimental Evidence from Medicare Drug Plans," Mathematica Policy Research Reports b5b408501b0147b89b7d124e8, Mathematica Policy Research.
    13. Duggan, Mark & Starc, Amanda & Vabson, Boris, 2016. "Who benefits when the government pays more? Pass-through in the Medicare Advantage program," Journal of Public Economics, Elsevier, vol. 141(C), pages 50-67.
    14. Liran Einav & Amy Finkelstein & Maria Polyakova, 2016. "Private Provision of Social Insurance: Drug-specific Price Elasticities and Cost Sharing in Medicare Part D," NBER Working Papers 22277, National Bureau of Economic Research, Inc.
    15. Patrick Arni & Davide Dragone & Lorenz Goette & Nicolas R. Ziebarth, 2020. "Biased Health Perceptions and Risky Health Behaviors: Theory and Evidence," Working Papers wp1146, Dipartimento Scienze Economiche, Universita' di Bologna.
    16. Florian Heiss & Adam Leive & Daniel McFadden & Joachim Winter, 2012. "Plan Selection in Medicare Part D: Evidence from Administrative Data," NBER Working Papers 18166, National Bureau of Economic Research, Inc.
    17. Chorniy, Anna & Miller, Daniel & Tang, Tilan, 2020. "Mergers in Medicare Part D: Assessing market power, cost efficiencies, and bargaining power," International Journal of Industrial Organization, Elsevier, vol. 68(C).
    18. Vetter, Stefan & Heiss, Florian & McFadden, Daniel & Winter, Joachim, 2012. "Risk attitudes and Medicare Part D enrollment decisions," Discussion Paper Series of SFB/TR 15 Governance and the Efficiency of Economic Systems 373, Free University of Berlin, Humboldt University of Berlin, University of Bonn, University of Mannheim, University of Munich.
    19. Benjamin R. Handel & Jonathan T. Kolstad & Johannes Spinnewijn, 2019. "Information Frictions and Adverse Selection: Policy Interventions in Health Insurance Markets," The Review of Economics and Statistics, MIT Press, vol. 101(2), pages 326-340, May.
    20. Christian Bünnings & Hendrik Schmitz & Harald Tauchmann & Nicolas R. Ziebarth, 2015. "How Health Plan Enrollees Value Prices Relative to Supplemental Benefits and Service Quality," SOEPpapers on Multidisciplinary Panel Data Research 741, DIW Berlin, The German Socio-Economic Panel (SOEP).
    21. Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2017. "Information, Switching Costs, and Consumer Choice: Evidence from Two Randomized Field Experiments in Swedish Primary Health Care," Working Papers 2017:7, Lund University, Department of Economics, revised 27 Jun 2018.
    22. Norton, E.C., 2016. "Health and Long-Term Care," Handbook of the Economics of Population Aging, in: Piggott, John & Woodland, Alan (ed.), Handbook of the Economics of Population Aging, edition 1, volume 1, chapter 0, pages 951-989, Elsevier.
    23. Janssen, Aljoscha & Granlund, David, 2023. "The importance of the first generic substitution: Evidence from Sweden," Journal of Economic Behavior & Organization, Elsevier, vol. 213(C), pages 1-25.
    24. Howard Kunreuther & Mark Pauly, 2022. "Do people have a bias for low deductible insurance?," Journal of Risk and Uncertainty, Springer, vol. 64(1), pages 1-17, February.
    25. Janssen, Aljoscha & Granlund, David, 2022. "The Importance of the First Generic Substitution: Evidence from Sweden," Working Paper Series 1428, Research Institute of Industrial Economics.
    26. Cornel Kaufmann & Tobias Mueller & Andreas Hefti & Stefan Boes, 2018. "Does personalized information improve health plan choices when individuals are distracted?," Diskussionsschriften dp1808, Universitaet Bern, Departement Volkswirtschaft.
    27. Michael P. Keane & Jonathan D. Ketcham & Nicolai V. Kuminoff & Timothy Neal, 2019. "Evaluating Consumers' Choices of Medicare Part D Plans: A Study in Behavioral Welfare Economics," NBER Working Papers 25652, National Bureau of Economic Research, Inc.
    28. Fleitas, Sebastian, 2020. "Who benefits when inertia is reduced? Competition, quality and returns to skill in health care markets," CEPR Discussion Papers 14292, C.E.P.R. Discussion Papers.
    29. Alycia Chin & Charles J. Romeo, 2022. "Repeat use of short‐term credit: The case of deposit advance products," Journal of Consumer Affairs, Wiley Blackwell, vol. 56(4), pages 1705-1726, December.
    30. McCarthy, Ian M., 2018. "Quality disclosure and the timing of insurers’ adjustments: Evidence from medicare advantage," Journal of Health Economics, Elsevier, vol. 61(C), pages 13-26.
    31. Dahl, Gordon B. & Forbes, Silke J., 2023. "Doctor switching costs," Journal of Public Economics, Elsevier, vol. 221(C).
    32. Withagen-Koster, Anja A. & van Kleef, Richard C. & Eijkenaar, Frank, 2023. "Predictable profits and losses in a health insurance market with risk equalization: A multiple-contract period perspective," Health Policy, Elsevier, vol. 131(C).
    33. Jason Abaluck & Jonathan Gruber, 2013. "Evolving Choice Inconsistencies in Choice of Prescription Drug Insurance," NBER Working Papers 19163, National Bureau of Economic Research, Inc.
    34. Christos Genakos & Tobias Kretschmer & Ambre Nicolle, 2021. "Strategic confusopoly: evidence from the UK mobile market," CEP Discussion Papers dp1810, Centre for Economic Performance, LSE.
    35. Hodor, Michal, 2021. "Family health spillovers: evidence from the RAND health insurance experiment," Journal of Health Economics, Elsevier, vol. 79(C).
    36. Shuo Zhang & Tat Y. Chan & Xueming Luo & Xiaoyi Wang, 2022. "Time-Inconsistent Preferences and Strategic Self-Control in Digital Content Consumption," Marketing Science, INFORMS, vol. 41(3), pages 616-636, May.
    37. Andrew Stocking & James Baumgardner & Melinda Buntin & Anna Cook, 2014. "Assessing the Design of the Low-Income Subsidy Program in Medicare Part D: Working Paper 2014-07," Working Papers 49451, Congressional Budget Office.
    38. Nathan Kettlewell, 2020. "Policy Choice and Product Bundling in a Complicated Health Insurance Market: Do People Get It Right?," Journal of Human Resources, University of Wisconsin Press, vol. 55(2), pages 566-610.
    39. Francesco Decarolis & Maria Polyakova & Stephen P. Ryan, 2020. "Subsidy Design in Privately Provided Social Insurance: Lessons from Medicare Part D," Journal of Political Economy, University of Chicago Press, vol. 128(5), pages 1712-1752.
    40. Kurt Lavetti & Kosali Simon, 2016. "Strategic Formulary Design in Medicare Part D Plans," NBER Working Papers 22338, National Bureau of Economic Research, Inc.
    41. Powell, David & Pacula, Rosalie Liccardo & Taylor, Erin, 2020. "How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D," Journal of Health Economics, Elsevier, vol. 71(C).
    42. Johannes Abeler & David Huffman & Colin Raymond, 2023. "Incentive Complexity, Bounded Rationality and Effort Provision," Economics Series Working Papers 1012, University of Oxford, Department of Economics.
    43. Wuppermann, Amelie C. & Bauhoff, Sebastian & Grabka, Markus M., 2014. "The Price Sensitivity of Health Plan Choice: Evidence from Retirees in the German Social Health Insurance," Discussion Papers in Economics 21080, University of Munich, Department of Economics.
    44. Peter Spittal, 2022. "Benefit Salience and Labour Supply," Bristol Economics Discussion Papers 22/764, School of Economics, University of Bristol, UK.
    45. Yeo, Jungwon & Miller, Daniel P., 2018. "Estimating switching costs with market share data: an application to Medicare Part D," International Journal of Industrial Organization, Elsevier, vol. 61(C), pages 459-501.
    46. Andrew T. Ching & Tülin Erdem & Michael P. Keane, 2017. "Empirical Models of Learning Dynamics: A Survey of Recent Developments," International Series in Operations Research & Management Science, in: Berend Wierenga & Ralf van der Lans (ed.), Handbook of Marketing Decision Models, edition 2, chapter 0, pages 223-257, Springer.
    47. Naomi C. Sacks & James F. Burgess & Howard J. Cabral & Steven D. Pizer, 2017. "Myopic and Forward Looking Behavior in Branded Oral Anti‐Diabetic Medication Consumption: An Example from Medicare Part D," Health Economics, John Wiley & Sons, Ltd., vol. 26(6), pages 753-764, June.
    48. Aviv Nevo & John L. Turner & Jonathan W. Williams, 2015. "Usage-Based Pricing and Demand for Residential Broadband," NBER Working Papers 21321, National Bureau of Economic Research, Inc.
    49. Andrew Stocking & James Baumgardner & Melinda Buntin & Anna Cook, 2014. "Examining the Number of Competitors and the Cost of Medicare Part D: Working Paper 2014-04," Working Papers 45553, Congressional Budget Office.
    50. Jonathan Gruber, 2017. "Delivering Public Health Insurance through Private Plan Choice in the United States," Journal of Economic Perspectives, American Economic Association, vol. 31(4), pages 3-22, Fall.
    51. Francesco Decarolis & Andrea Guglielmo & Calvin Luscombe, 2017. "Open Enrollment Periods and Plan Choices," NBER Working Papers 24156, National Bureau of Economic Research, Inc.
    52. Jason Abaluck & Jonathan Gruber & Ashley Swanson, 2015. "Prescription Drug Use under Medicare Part D: A Linear Model of Nonlinear Budget Sets," NBER Working Papers 20976, National Bureau of Economic Research, Inc.
    53. Leemore Dafny & Jonathan Gruber & Christopher Ody, 2014. "More Insurers Lower Premiums: Evidence from Initial Pricing in the Health Insurance Marketplaces," NBER Working Papers 20140, National Bureau of Economic Research, Inc.
    54. Anja Lambrecht & Katja Seim & Naufel Vilcassim & Amar Cheema & Yuxin Chen & Gregory Crawford & Kartik Hosanagar & Raghuram Iyengar & Oded Koenigsberg & Robin Lee & Eugenio Miravete & Ozge Sahin, 2012. "Price discrimination in service industries," Marketing Letters, Springer, vol. 23(2), pages 423-438, June.
    55. Christina M. Dalton & Gautam Gowrisankaran & Robert Town, 2015. "Salience, Myopia, and Complex Dynamic Incentives: Evidence from Medicare Part D," NBER Working Papers 21104, National Bureau of Economic Research, Inc.
    56. Jonathan D. Ketcham & Nicolai V. Kuminoff & Christopher A. Powers, 2016. "Estimating the Heterogeneous Welfare Effects of Choice Architecture: An Application to the Medicare Prescription Drug Insurance Market," NBER Working Papers 22732, National Bureau of Economic Research, Inc.
    57. Florian Heiss & Daniel McFadden & Joachim Winter & Amelie Wuppermann & Bo Zhou, 2016. "Inattention and Switching Costs as Sources of Inertia in Medicare Part D," NBER Working Papers 22765, National Bureau of Economic Research, Inc.
    58. Abeler, Johannes & Huffman, David B. & Raymond, Collin, 2023. "Incentive Complexity, Bounded Rationality and Effort Provision," IZA Discussion Papers 16284, Institute of Labor Economics (IZA).
    59. Jonathan Gruber & Benjamin R. Handel & Samuel H. Kina & Jonathan T. Kolstad, 2020. "Managing Intelligence: Skilled Experts and AI in Markets for Complex Products," NBER Working Papers 27038, National Bureau of Economic Research, Inc.
    60. Juan Pablo Atal, 2019. "Lock-in in Dynamic Health Insurance Contracts: Evidence from Chile," PIER Working Paper Archive 19-020, Penn Institute for Economic Research, Department of Economics, University of Pennsylvania.
    61. Raf Van Gastel & Tim Goedemé & Julie Janssens & Eva Lefevere & Rik Lemkens, 2017. "A Reminder to Pay Less for Healthcare: take-up of Increased Reimbursement in a large-scale randomized field experiment," Working Papers 1712, Herman Deleeck Centre for Social Policy, University of Antwerp.
    62. Decarolis, Francesco, 2015. "The unintended effects of the Medicare Part D low income subsidy," Health Policy, Elsevier, vol. 119(5), pages 597-603.
    63. Abaluck, Jason & Gruber, Jonathan & Swanson, Ashley, 2018. "Prescription drug use under Medicare Part D: A linear model of nonlinear budget sets," Journal of Public Economics, Elsevier, vol. 164(C), pages 106-138.
    64. M. Kate Bundorf & Maria Polyakova & Ming Tai-Seale, 2019. "How do Humans Interact with Algorithms? Experimental Evidence from Health Insurance," NBER Working Papers 25976, National Bureau of Economic Research, Inc.
    65. Afendulis, Christopher C. & Sinaiko, Anna D. & Frank, Richard G., 2015. "Dominated choices and Medicare Advantage enrollment," Journal of Economic Behavior & Organization, Elsevier, vol. 119(C), pages 72-83.
    66. Itai Ater & Vardit Landsman, 2013. "Do Customers Learn from Experience? Evidence from Retail Banking," Management Science, INFORMS, vol. 59(9), pages 2019-2035, September.
    67. Saurabh Bhargava & George Loewenstein & Justin Sydnor, 2015. "Do Individuals Make Sensible Health Insurance Decisions? Evidence from a Menu with Dominated Options," NBER Working Papers 21160, National Bureau of Economic Research, Inc.
    68. Benjamin R. Handel & Jonathan T. Kolstad, 2013. "Health Insurance for "Humans": Information Frictions, Plan Choice, and Consumer Welfare," NBER Working Papers 19373, National Bureau of Economic Research, Inc.

  7. Andrew Epstein & Jonathan D. Ketcham & Sean Nicholson, 2008. "Professional Partnerships and Matching in Obstetrics," NBER Working Papers 14070, National Bureau of Economic Research, Inc.

    Cited by:

    1. Andrew Epstein & Sean Nicholson, 2005. "The Formation and Evolution of Physician Treatment Styles: An Application to Cesarean Sections," NBER Working Papers 11549, National Bureau of Economic Research, Inc.

  8. Jonathan D. Ketcham & Kosali Simon, 2008. "Medicare Part D's Effects on Elderly Drug Costs and Utilization," NBER Working Papers 14326, National Bureau of Economic Research, Inc.

    Cited by:

    1. Lakdawalla, Darius & Sood, Neeraj & Gu, Qian, 2013. "Pharmaceutical advertising and Medicare Part D," Journal of Health Economics, Elsevier, vol. 32(6), pages 1356-1367.
    2. Abe Dunn & Adam Hale Shapiro, 2015. "Does Medicare Part D save lives?," Working Paper Series 2015-4, Federal Reserve Bank of San Francisco.
    3. Gary V. Engelhardt & Jonathan Gruber, 2010. "Medicare Part D and the Financial Protection of the Elderly," NBER Working Papers 16155, National Bureau of Economic Research, Inc.
    4. Liran Einav & Amy Finkelstein & Maria Polyakova, 2016. "Private Provision of Social Insurance: Drug-specific Price Elasticities and Cost Sharing in Medicare Part D," NBER Working Papers 22277, National Bureau of Economic Research, Inc.
    5. Banerjee, Tannista & Siebert, Ralph, 2017. "Dynamic impact of uncertainty on R&D cooperation formation and research performance: Evidence from the bio-pharmaceutical industry," Research Policy, Elsevier, vol. 46(7), pages 1255-1271.
    6. Denise Doiron & Denzil G Fiebig & Agne Suziedelyte, 2013. "Hips and hearts: the variation in incentive effects of insurance across hospital procedures," Discussion Papers 2013-14, School of Economics, The University of New South Wales.
    7. Darius Lakdawalla & Wesley Yin, 2009. "Insurer Bargaining and Negotiated Drug Prices in Medicare Part D," NBER Working Papers 15330, National Bureau of Economic Research, Inc.
    8. Blume-Kohout, Margaret E. & Sood, Neeraj, 2013. "Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development," Journal of Public Economics, Elsevier, vol. 97(C), pages 327-336.
    9. Alpert, Abby, 2016. "The anticipatory effects of Medicare Part D on drug utilization," Journal of Health Economics, Elsevier, vol. 49(C), pages 28-45.
    10. Alpert, Abby & Lakdawalla, Darius & Sood, Neeraj, 2023. "Prescription drug advertising and drug utilization: The role of Medicare Part D," Journal of Public Economics, Elsevier, vol. 221(C).
    11. David B. Ridley, 2015. "Payments, Promotion, And The Purple Pill," Health Economics, John Wiley & Sons, Ltd., vol. 24(1), pages 86-103, January.
    12. Hall Anne E., 2016. "Estimating Regression-Based Medical Care Expenditure Indexes for Medicare Advantage Enrollees," Forum for Health Economics & Policy, De Gruyter, vol. 19(2), pages 261-297, December.
    13. Matthew T. Knowles, 2022. "How access to addictive drugs affects the supply of substance abuse treatment: Evidence from Medicare Part D," Health Economics, John Wiley & Sons, Ltd., vol. 31(8), pages 1649-1675, August.
    14. Robert Kaestner & Cuiping Long & G. Caleb Alexander, 2014. "Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence from Medicare Part D," NBER Working Papers 19948, National Bureau of Economic Research, Inc.
    15. Francesco Decarolis & Maria Polyakova & Stephen P. Ryan, 2020. "Subsidy Design in Privately Provided Social Insurance: Lessons from Medicare Part D," Journal of Political Economy, University of Chicago Press, vol. 128(5), pages 1712-1752.
    16. Powell, David & Pacula, Rosalie Liccardo & Taylor, Erin, 2020. "How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D," Journal of Health Economics, Elsevier, vol. 71(C).
    17. Gary V. Engelhardt & Jonathan Gruber, 2009. "Medicare Part D and the Financial Protection of the Elderly," Working Papers, Center for Retirement Research at Boston College wp2009-24, Center for Retirement Research, revised Oct 2009.
    18. Darius N. Lakdawalla & Wesley Yin, 2010. "Insurers' Negotiating Leverage and the External Effects of Medicare Part D," NBER Working Papers 16251, National Bureau of Economic Research, Inc.
    19. Gary V. Engelhardt & Jonathan Gruber, 2011. "Medicare Part D and the Financial Protection of the Elderly," American Economic Journal: Economic Policy, American Economic Association, vol. 3(4), pages 77-102, November.
    20. Claudio Lucarelli & Sean Nicholson & Minjae Song, 2010. "Bundling Among Rivals: A Case of Pharmaceutical Cocktails," NBER Working Papers 16321, National Bureau of Economic Research, Inc.
    21. David Dranove & Craig Garthwaite & Manuel I. Hermosilla, 2020. "Expected Profits and The Scientific Novelty of Innovation," NBER Working Papers 27093, National Bureau of Economic Research, Inc.
    22. Florian Heiss & Daniel McFadden & Joachim Winter, 2009. "Regulation of private health insurance markets: Lessons from enrollment, plan type choice, and adverse selection in Medicare Part D," NBER Working Papers 15392, National Bureau of Economic Research, Inc.
    23. Ghosh, Ausmita & Simon, Kosali & Sommers, Benjamin D., 2019. "The Effect of Health Insurance on Prescription Drug Use Among Low-Income Adults:Evidence from Recent Medicaid Expansions," Journal of Health Economics, Elsevier, vol. 63(C), pages 64-80.

  9. Patricia M. Danzon & Jonathan D. Ketcham, 2003. "Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand," NBER Working Papers 10007, National Bureau of Economic Research, Inc.

    Cited by:

    1. Herr, Annika & Suppliet, Moritz, 2012. "Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany," DICE Discussion Papers 48, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
    2. Annika Herr & Torben Stühmeier & Tobias Wenzel, 2023. "More cost‐sharing, less cost? Evidence on reference price drugs," Health Economics, John Wiley & Sons, Ltd., vol. 32(2), pages 413-435, February.
    3. Brekke, Kurt R. & Canta, Chiara & Straume, Odd Rune, 2015. "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," Discussion Paper Series in Economics 11/2015, Norwegian School of Economics, Department of Economics.
    4. Bardey, David & Bommier, Antoine & Jullien, Bruno, 2009. "Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry," IDEI Working Papers 432, Institut d'Économie Industrielle (IDEI), Toulouse.
    5. Moreno Gigi & van Eijndhoven Emma & Benner Jennifer & Sullivan Jeffrey, 2017. "The Long-Term Impact of Price Controls in Medicare Part D," Forum for Health Economics & Policy, De Gruyter, vol. 20(2), pages 1-56, December.
    6. Denoyel, Victoire & Alfandari, Laurent & Thiele, Aurélie, 2017. "Optimizing healthcare network design under reference pricing and parameter uncertainty," European Journal of Operational Research, Elsevier, vol. 263(3), pages 996-1006.
    7. Kurt R. Brekke & Astrid L. Grasdal & Tor Helge Holmås, 2007. "Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?," CESifo Working Paper Series 2059, CESifo.
    8. Pamina Koenig & Megan Macgarvie, 2009. "Regulatory policy and the location of bio-pharmaceutical FDI in Europe," Working Papers halshs-00566800, HAL.
    9. Dubois, Pierre & de Mouzon, Olivier & Scott Morton, Fiona & Seabright, Paul, 2011. "Market Size and Pharmaceutical Innovation," IDEI Working Papers 670, Institut d'Économie Industrielle (IDEI), Toulouse, revised Mar 2014.
    10. Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2010. "Reference Pricing, Competition, and Pharmaceutical Expenditures: Theory and Evidence from a Natural Experiment," CESifo Working Paper Series 3258, CESifo.
    11. Neil Hawkins & David A. Scott, 2011. "Reimbursement and value‐based pricing: stratified cost‐effectiveness analysis may not be the last word," Health Economics, John Wiley & Sons, Ltd., vol. 20(6), pages 688-698, June.
    12. Kurt R. Brekke & Ingrid Königbauer & Odd Rune Straume, 2006. "Reference Pricing of Pharmaceuticals," CESifo Working Paper Series 1825, CESifo.
    13. Chiara Bonassi & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2007. "Regolazione, innovazione e ciclo di vita dei prodotti - per una riforma del pricing al lancio e della governance della spesa nella farmaceutica pubblica," Working Papers CERM 02-2007, Competitività, Regole, Mercati (CERM).
    14. Kurt R. Brekke & Chiara Canta & Odd Rune Straume, 2015. "Reference pricing with endogenous generic entry," NIPE Working Papers 2/2015, NIPE - Universidade do Minho.
    15. Chiara Bonassi & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2007. "Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico," Working Papers CERM 04-2007, Competitività, Regole, Mercati (CERM).
    16. Melanie Büssgen & Tom Stargardt, 2023. "Does health technology assessment compromise access to pharmaceuticals?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(3), pages 437-451, April.
    17. Varol, Nebibe & Costa-i-Font, Joan & McGuire, Alistair, 2010. "Do international launch strategies of pharmaceutical corporations respond to changes in the regulatory environment?," LSE Research Online Documents on Economics 29972, London School of Economics and Political Science, LSE Library.
    18. Civan Abdulkadir & Maloney Michael T., 2009. "The Effect of Price on Pharmaceutical R&D," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 9(1), pages 1-24, April.
    19. Maria-Isabel Farfan-Portet & Carine Van de Voorde & France Vrijens & Robert Vander Stichele, 2012. "Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(3), pages 301-313, June.
    20. Nebibe Varol & Joan Costa-i-Font & Alistair McGuire, 2011. "Explaining Early Adoption on New Medicines: Regulation, Innovation and Scale," CESifo Working Paper Series 3459, CESifo.
    21. Kremer, Michael & Snyder, Christopher, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global D," CEPR Discussion Papers 12751, C.E.P.R. Discussion Papers.
    22. Pamina Koenig & Megan Macgarvie, 2011. "Regulatory policy and the location of bio-pharmaceutical foreign direct investment in Europe," Post-Print halshs-00754522, HAL.
    23. Geng, Difei & Saggi, Kamal, 2020. "Optimal price regulations in international pharmaceutical markets with generic competition," Journal of Health Economics, Elsevier, vol. 71(C).
    24. Patricia M. Danzon & Eric L. Keuffel, 2014. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484, National Bureau of Economic Research, Inc.
    25. F. Antoñanzas & C. A. Juárez-Castelló & R. Rodríguez-Ibeas, 2017. "Endogenous versus exogenous generic reference pricing for pharmaceuticals," International Journal of Health Economics and Management, Springer, vol. 17(4), pages 413-432, December.
    26. Claude Montmarquette & Stéphanie Boulenger & Joanne Castonguay, 2014. "Les risques liés à la création de PHARMA-QUEBEC," CIRANO Project Reports 2014rp-05, CIRANO.
    27. Suppliet, Moritz & Herr, Annika, 2016. "Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets," Other publications TiSEM 6430293b-fde9-4f91-ab35-3, Tilburg University, School of Economics and Management.
    28. Hanna Koskinen & Elina Ahola & Leena Saastamoinen & Hennamari Mikkola & Jaana Martikainen, 2014. "The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland," Health Economics Review, Springer, vol. 4(1), pages 1-10, December.
    29. Boris Augurzky & Silja Göhlmann & Stefan Greß & Jürgen Wasem, 2009. "Effects of the German reference drug program on ex‐factory prices of prescription drugs: a panel data approach," Health Economics, John Wiley & Sons, Ltd., vol. 18(4), pages 421-436, April.
    30. Götze, Ralf, 2010. "The changing role of the state in the Dutch healthcare system," TranState Working Papers 141, University of Bremen, Collaborative Research Center 597: Transformations of the State.
    31. Kurt Brekke & Dag Dalen & Tor Holmås, 2014. "Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(9), pages 937-951, December.
    32. Ghislandi, Simone, 2011. "Competition and the Reference Pricing Scheme for pharmaceuticals," Journal of Health Economics, Elsevier, vol. 30(6), pages 1137-1149.
    33. Michael Kremer & Christopher M. Snyder, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals," NBER Working Papers 24206, National Bureau of Economic Research, Inc.
    34. Königbauer, Ingrid, 2006. "Dealing with Rising Health Care Costs: The Case of Pharmaceuticals," Munich Dissertations in Economics 5640, University of Munich, Department of Economics.
    35. Ivan Moreno-Torres, 2011. "Generic drugs in Spain: price competition vs. moral hazard," Working Papers XREAP2011-04, Xarxa de Referència en Economia Aplicada (XREAP), revised May 2011.
    36. Stefan Stremersch & Aurélie Lemmens, 2009. "Sales Growth of New Pharmaceuticals Across the Globe: The Role of Regulatory Regimes," Marketing Science, INFORMS, vol. 28(4), pages 690-708, 07-08.
    37. Helga De Doncker, 2006. "R&D in the Belgian Pharmaceutical Sector," Working Paper Document 106, National Bank of Belgium.
    38. François Bocquet & Pascal Paubel & Isabelle Fusier & Anne-Laure Cordonnier & Martine Sinègre & Claude Le Pen, 2015. "Biosimilar Versus Patented Erythropoietins: Learning from 5 Years of European and Japanese Experience," Applied Health Economics and Health Policy, Springer, vol. 13(1), pages 47-59, February.
    39. Augurzky, Boris & Göhlmann, Silja & Greß, Stefan & Wasem, Jürgen, 2006. "The Effects of Reference Pricing on Ex-factory Prices of Rx Drugs in Germany - A Panel Data Approach," RWI Discussion Papers 46, RWI - Leibniz-Institut für Wirtschaftsforschung.
    40. Matteo Galizzi & Simone Ghislandi & Marisa Miraldo, 2011. "Effects of Reference Pricing in Pharmaceutical Markets," PharmacoEconomics, Springer, vol. 29(1), pages 17-33, January.
    41. Stremersch, S. & Lemmens, A., 2008. "Sales Growth of New Pharmaceuticals Across the Globe: The Role of Regulatory Regimes," ERIM Report Series Research in Management ERS-2008-026-MKT, Erasmus Research Institute of Management (ERIM), ERIM is the joint research institute of the Rotterdam School of Management, Erasmus University and the Erasmus School of Economics (ESE) at Erasmus University Rotterdam.
    42. Rifat A. Atun & Ipek Gurol-Urganci & Desmond Sheridan, 2007. "Uptake And Diffusion Of Pharmaceutical Innovations In Health Systems," International Journal of Innovation Management (ijim), World Scientific Publishing Co. Pte. Ltd., vol. 11(02), pages 299-321.
    43. James W. Shaw & William C. Horrace & Ronald J. Vogel, 2005. "The Determinants of Life Expectancy: An Analysis of the OECD Health Data," Southern Economic Journal, John Wiley & Sons, vol. 71(4), pages 768-783, April.
    44. François Bocquet & Pascal Paubel & Isabelle Fusier & Anne-Laure Cordonnier & Claude Pen & Martine Sinègre, 2014. "Biosimilar Granulocyte Colony-Stimulating Factor Uptakes in the EU-5 Markets: A Descriptive Analysis," Applied Health Economics and Health Policy, Springer, vol. 12(3), pages 315-326, June.

Articles

  1. Keane, Michael & Ketcham, Jonathan & Kuminoff, Nicolai & Neal, Timothy, 2021. "Evaluating consumers’ choices of Medicare Part D plans: A study in behavioral welfare economics," Journal of Econometrics, Elsevier, vol. 222(1), pages 107-140.
    See citations under working paper version above.
  2. Jonathan D. Ketcham & Nicolai V. Kuminoff & Christopher A. Powers, 2019. "Estimating The Heterogeneous Welfare Effects Of Choice Architecture," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 60(3), pages 1171-1208, August.

    Cited by:

    1. Michael Geruso & Timothy J. Layton & Grace McCormack & Mark Shepard, 2023. "The Two-Margin Problem in Insurance Markets," The Review of Economics and Statistics, MIT Press, vol. 105(2), pages 237-257, March.
    2. Donald S. Kenkel & Sida Peng & Michael F. Pesko & Hua Wang, 2020. "Mostly harmless regulation? Electronic cigarettes, public policy, and consumer welfare," Health Economics, John Wiley & Sons, Ltd., vol. 29(11), pages 1364-1377, November.
    3. Huse, Cristian & Lucinda, Claudio & Cardoso, Andre Ribeiro, 2020. "Consumer response to energy label policies: Evidence from the Brazilian energy label program," Energy Policy, Elsevier, vol. 138(C).
    4. Sai Krishnan S. & Subramanian S. Iyer & Sai Balaji SMR, 2022. "Insights from behavioral economics for policymakers of choice‐based health insurance markets: A scoping review," Risk Management and Insurance Review, American Risk and Insurance Association, vol. 25(2), pages 115-143, June.

  3. Jonathan D. Ketcham & Nicolai V. Kuminoff & Christopher A. Powers, 2016. "Choice Inconsistencies among the Elderly: Evidence from Plan Choice in the Medicare Part D Program: Comment," American Economic Review, American Economic Association, vol. 106(12), pages 3932-3961, December.

    Cited by:

    1. Jason Abaluck & Jonathan Gruber, 2016. "Choice Inconsistencies among the Elderly: Evidence from Plan Choice in the Medicare Part D Program: Reply," American Economic Review, American Economic Association, vol. 106(12), pages 3962-3987, December.
    2. Patrick Arni & Davide Dragone & Lorenz Goette & Nicolas R. Ziebarth, 2020. "Biased Health Perceptions and Risky Health Behaviors: Theory and Evidence," Working Papers wp1146, Dipartimento Scienze Economiche, Universita' di Bologna.
    3. Anell, Anders & Dietrichson, Jens & Ellegård, Lina Maria & Kjellsson, Gustav, 2017. "Information, Switching Costs, and Consumer Choice: Evidence from Two Randomized Field Experiments in Swedish Primary Health Care," Working Papers 2017:7, Lund University, Department of Economics, revised 27 Jun 2018.
    4. Michael P. Keane & Jonathan D. Ketcham & Nicolai V. Kuminoff & Timothy Neal, 2019. "Evaluating Consumers' Choices of Medicare Part D Plans: A Study in Behavioral Welfare Economics," NBER Working Papers 25652, National Bureau of Economic Research, Inc.
    5. Yukiko Hashida & Eli P. Fenichel, 2022. "Valuing natural capital when management is dominated by periods of inaction," American Journal of Agricultural Economics, John Wiley & Sons, vol. 104(2), pages 791-811, March.
    6. Justine Hastings & Jesse M. Shapiro, 2018. "How Are SNAP Benefits Spent? Evidence from a Retail Panel," American Economic Review, American Economic Association, vol. 108(12), pages 3493-3540, December.
    7. Jonathan Gruber, 2017. "Delivering Public Health Insurance through Private Plan Choice in the United States," Journal of Economic Perspectives, American Economic Association, vol. 31(4), pages 3-22, Fall.
    8. Jonathan D. Ketcham & Nicolai V. Kuminoff & Christopher A. Powers, 2016. "Estimating the Heterogeneous Welfare Effects of Choice Architecture: An Application to the Medicare Prescription Drug Insurance Market," NBER Working Papers 22732, National Bureau of Economic Research, Inc.
    9. Florian Heiss & Daniel McFadden & Joachim Winter & Amelie Wuppermann & Bo Zhou, 2016. "Inattention and Switching Costs as Sources of Inertia in Medicare Part D," NBER Working Papers 22765, National Bureau of Economic Research, Inc.
    10. M. Kate Bundorf & Maria Polyakova & Ming Tai-Seale, 2019. "How do Humans Interact with Algorithms? Experimental Evidence from Health Insurance," NBER Working Papers 25976, National Bureau of Economic Research, Inc.
    11. Tomas Pedro Sanguinetti, 2019. "How Do Couples Choose Individual Insurance Plans? Evidence from Medicare Part D," 2019 Papers psa1760, Job Market Papers.

  4. Jonathan D. Ketcham & Claudio Lucarelli & Christopher A. Powers, 2015. "Paying Attention or Paying Too Much in Medicare Part D," American Economic Review, American Economic Association, vol. 105(1), pages 204-233, January.

    Cited by:

    1. Bjørn-Atle Reme & Helene Lie Røhr & Morten Sæthre, 2022. "Inattention in Contract Markets: Evidence from a Consolidation of Options in Telecom," Management Science, INFORMS, vol. 68(2), pages 1019-1038, February.
    2. Sinaiko, Anna & Zeckhauser, Richard, 2016. "Enrollee Choices after Their Health Plans Are Terminated: Default Effects versus Persistent Preferences," Working Paper Series rwp16-055, Harvard University, John F. Kennedy School of Government.
    3. Pilny, Adam & Wübker, Ansgar & Ziebarth, Nicolas R., 2017. "Introducing Risk Adjustment and Free Health Plan Choice in Employer-Based Health Insurance: Evidence from Germany," VfS Annual Conference 2017 (Vienna): Alternative Structures for Money and Banking 168121, Verein für Socialpolitik / German Economic Association.
    4. Scott Morton, Fiona & Ho, Kate & Hogan, Joseph, 2015. "The Impact of Consumer Inattention on Insurer Pricing in the Medicare Part D Program," CEPR Discussion Papers 10976, C.E.P.R. Discussion Papers.
    5. Ulrike Malmendier, 2016. "The Bidder's Curse: Reply," American Economic Review, American Economic Association, vol. 106(4), pages 1195-1213, April.
    6. Drake, Coleman & Ryan, Conor & Dowd, Bryan, 2022. "Sources of inertia in the individual health insurance market," Journal of Public Economics, Elsevier, vol. 208(C).
    7. Jin, Haofeng & Lu, Zhentong & Huang, Liqiang & Dou, Junsheng, 2021. "Not too much nor too little: Salience bias in mobile plan choices," Telecommunications Policy, Elsevier, vol. 45(4).
    8. Shakeeb Khan & Fu Ouyang & Elie Tamer, 2020. "Inference on Semiparametric Multinomial Response Models," Discussion Papers Series 627, School of Economics, University of Queensland, Australia.
    9. Maria Polyakova, 2015. "Regulation of Insurance with Adverse Selection and Switching Costs: Evidence from Medicare Part D," NBER Working Papers 21541, National Bureau of Economic Research, Inc.
    10. Liran Einav & Amy Finkelstein & Maria Polyakova, 2016. "Private Provision of Social Insurance: Drug-specific Price Elasticities and Cost Sharing in Medicare Part D," NBER Working Papers 22277, National Bureau of Economic Research, Inc.
    11. Lavetti, Kurt & DeLeire, Thomas C. & Ziebarth, Nicolas R., 2023. "How do low-income enrollees in the affordable care act marketplaces respond to cost sharing?," ZEW Discussion Papers 23-049, ZEW - Leibniz Centre for European Economic Research.
    12. Shakeeb Khan & Fu Ouyang & Elie Tamer, 2019. "Inference on Semiparametric Multinomial Response Models," Boston College Working Papers in Economics 980, Boston College Department of Economics.
    13. Bischof, T.; Schmid, C.P.R.;, "undated". "Consumer Price Sensitivity and Health Plan Choice in a Regulated Competition Setting," Health, Econometrics and Data Group (HEDG) Working Papers 17/16, HEDG, c/o Department of Economics, University of York.
    14. Janssen, Aljoscha & Granlund, David, 2023. "The importance of the first generic substitution: Evidence from Sweden," Journal of Economic Behavior & Organization, Elsevier, vol. 213(C), pages 1-25.
    15. Ong, David, 2021. "Predicting choice-averse and choice-loving behaviors in a field experiment with actual shoppers," MPRA Paper 108384, University Library of Munich, Germany.
    16. Janssen, Aljoscha & Granlund, David, 2022. "The Importance of the First Generic Substitution: Evidence from Sweden," Working Paper Series 1428, Research Institute of Industrial Economics.
    17. Khan, S. & Ponomareva, M. & Tamer, E., 2023. "Identification of dynamic binary response models," Journal of Econometrics, Elsevier, vol. 237(1).
    18. David Ong, 2021. "Choice averse behavior and sampling risk: a field experiment with actual shoppers," Framed Field Experiments 00547, The Field Experiments Website.
    19. Michael P. Keane & Jonathan D. Ketcham & Nicolai V. Kuminoff & Timothy Neal, 2019. "Evaluating Consumers' Choices of Medicare Part D Plans: A Study in Behavioral Welfare Economics," NBER Working Papers 25652, National Bureau of Economic Research, Inc.
    20. Jason Abaluck & Jonathan Gruber, 2016. "Improving the Quality of Choices in Health Insurance Markets," NBER Working Papers 22917, National Bureau of Economic Research, Inc.
    21. Janssen, Aljoscha, 2020. "Switching Costs, Brand Premia and Behavioral Pricing in the Pharmaceutical Market," Working Paper Series 1317, Research Institute of Industrial Economics.
    22. Shakeeb Khan & Maria Ponomareva & Elie Tamer, 2019. "Identification of Dynamic Panel Binary Response Models," Boston College Working Papers in Economics 979, Boston College Department of Economics.
    23. Shuo Zhang & Tat Y. Chan & Xueming Luo & Xiaoyi Wang, 2022. "Time-Inconsistent Preferences and Strategic Self-Control in Digital Content Consumption," Marketing Science, INFORMS, vol. 41(3), pages 616-636, May.
    24. Francesco Decarolis & Maria Polyakova & Stephen P. Ryan, 2020. "Subsidy Design in Privately Provided Social Insurance: Lessons from Medicare Part D," Journal of Political Economy, University of Chicago Press, vol. 128(5), pages 1712-1752.
    25. Andrew T. Ching & Tülin Erdem & Michael P. Keane, 2017. "Empirical Models of Learning Dynamics: A Survey of Recent Developments," International Series in Operations Research & Management Science, in: Berend Wierenga & Ralf van der Lans (ed.), Handbook of Marketing Decision Models, edition 2, chapter 0, pages 223-257, Springer.
    26. Tamara Bischof & Michael Gerfin & Tobias Mueller, 2021. "Attention Please! Health Plan Choice and (In-)Attention," Diskussionsschriften dp2111, Universitaet Bern, Departement Volkswirtschaft.
    27. Christina M. Dalton & Gautam Gowrisankaran & Robert Town, 2015. "Salience, Myopia, and Complex Dynamic Incentives: Evidence from Medicare Part D," NBER Working Papers 21104, National Bureau of Economic Research, Inc.
    28. Jonathan D. Ketcham & Nicolai V. Kuminoff & Christopher A. Powers, 2016. "Estimating the Heterogeneous Welfare Effects of Choice Architecture: An Application to the Medicare Prescription Drug Insurance Market," NBER Working Papers 22732, National Bureau of Economic Research, Inc.
    29. Florian Heiss & Daniel McFadden & Joachim Winter & Amelie Wuppermann & Bo Zhou, 2016. "Inattention and Switching Costs as Sources of Inertia in Medicare Part D," NBER Working Papers 22765, National Bureau of Economic Research, Inc.
    30. Jonathan D. Ketcham & Nicolai V. Kuminoff & Christopher A. Powers, 2016. "Choice Inconsistencies among the Elderly: Evidence from Plan Choice in the Medicare Part D Program: Comment," American Economic Review, American Economic Association, vol. 106(12), pages 3932-3961, December.
    31. Benjamin Handel & Joshua Schwartzstein, 2018. "Frictions or Mental Gaps: What's Behind the Information We (Don't) Use and When Do We Care?," Journal of Economic Perspectives, American Economic Association, vol. 32(1), pages 155-178, Winter.
    32. M. Kate Bundorf & Maria Polyakova & Ming Tai-Seale, 2019. "How do Humans Interact with Algorithms? Experimental Evidence from Health Insurance," NBER Working Papers 25976, National Bureau of Economic Research, Inc.
    33. Tomas Pedro Sanguinetti, 2019. "How Do Couples Choose Individual Insurance Plans? Evidence from Medicare Part D," 2019 Papers psa1760, Job Market Papers.

  5. Andrew J. Epstein & Jonathan D. Ketcham, 2014. "Information technology and agency in physicians' prescribing decisions," RAND Journal of Economics, RAND Corporation, vol. 45(2), pages 422-448, June.

    Cited by:

    1. Herr, Annika & Suppliet, Moritz, 2012. "Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany," DICE Discussion Papers 48, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
    2. Carey, Colleen & Lieber, Ethan M.J. & Miller, Sarah, 2021. "Drug firms’ payments and physicians’ prescribing behavior in Medicare Part D," Journal of Public Economics, Elsevier, vol. 197(C).
    3. Suppliet, Moritz, 2017. "Umbrella Branding in Pharmaceutical Markets," Discussion Paper 2017-034, Tilburg University, Tilburg Law and Economic Center.
    4. Margaret K. Kyle, 2019. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," NBER Chapters, in: Innovation Policy and the Economy, Volume 20, pages 95-123, National Bureau of Economic Research, Inc.
    5. Tianyan Hu & Sandra L. Decker & Shin-Yi Chou, 2017. "The impact of health insurance expansion on physician treatment choice: Medicare Part D and physician prescribing," International Journal of Health Economics and Management, Springer, vol. 17(3), pages 333-358, September.
    6. Avdic, Daniel & Blankart, Katharina, 2021. "A Hard Look at “Soft” Cost‐control Measures in Healthcare Organizations: Evidence from Preferred Drug Policies in Germany," CINCH Working Paper Series (since 2020) 74978, Duisburg-Essen University Library, DuEPublico.
    7. Suppliet, Moritz & Herr, Annika, 2016. "Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets," Other publications TiSEM 6430293b-fde9-4f91-ab35-3, Tilburg University, School of Economics and Management.
    8. Melissa Newham & Marica Valente, 2023. "The Cost of Influence:How Gifts to Physicians Shape Prescriptions and Drug Costs," Working Papers 2023-03, Faculty of Economics and Statistics, Universität Innsbruck.
    9. Zhu, Z.;, 2023. "The Value of Patients: Heterogenous Physician Learning and Generic Drug Diffusion," Health, Econometrics and Data Group (HEDG) Working Papers 23/12, HEDG, c/o Department of Economics, University of York.
    10. Kyle, Margaret K., 2022. "Incentives for pharmaceutical innovation: What’s working, what’s lacking," International Journal of Industrial Organization, Elsevier, vol. 84(C).

  6. Lin, Haizhen & Ketcham, Jonathan D. & Rosenquist, James N. & Simon, Kosali I., 2013. "Financial distress and use of mental health care: Evidence from antidepressant prescription claims," Economics Letters, Elsevier, vol. 121(3), pages 449-453.
    See citations under working paper version above.
  7. Jonathan D. Ketcham & Claudio Lucarelli & Eugenio J. Miravete & M. Christopher Roebuck, 2012. "Sinking, Swimming, or Learning to Swim in Medicare Part D," American Economic Review, American Economic Association, vol. 102(6), pages 2639-2673, October.
    See citations under working paper version above.
  8. Andrew J. Epstein & Jonathan D. Ketcham & Sean Nicholson, 2010. "Specialization and matching in professional services firms," RAND Journal of Economics, RAND Corporation, vol. 41(4), pages 811-834, December.

    Cited by:

    1. Simona Grassi & Ching-to Albert Ma, 2016. "Information Acquisition, Referral, and Organization," Boston University - Department of Economics - Working Papers Series wp2016-005, Boston University - Department of Economics.
    2. Ryan C. McDevitt & James W. Roberts, 2014. "Market structure and gender disparity in health care: preferences, competition, and quality of care," RAND Journal of Economics, RAND Corporation, vol. 45(1), pages 116-139, March.
    3. Larry G. Epstein & Hiroaki Kaido & Kyoungwon Seo, 2015. "Robust Confidence Regions for Incomplete Models," Boston University - Department of Economics - Working Papers Series wp2015-008, Boston University - Department of Economics.
    4. Liu, Ting & Albert Ma, Ching-to & Mak, Henry Y., 2018. "Incentives for motivated experts in a partnership," Journal of Economic Behavior & Organization, Elsevier, vol. 152(C), pages 296-313.
    5. Leila Agha & Keith Marzilli Ericson & Kimberley H. Geissler & James B. Rebitzer, 2022. "Team Relationships and Performance: Evidence from Healthcare Referral Networks," Management Science, INFORMS, vol. 68(5), pages 3735-3754, May.
    6. Marie Allard & Izabela Jelovac & Pierre-Thomas Léger, 2014. "Payment mechanism and GP self-selection: capitation versus fee for service," International Journal of Health Economics and Management, Springer, vol. 14(2), pages 143-160, June.
    7. Godager , Geir & Scott, Anthony, 2023. "Physician Behavior and Health Outcomes," HERO Online Working Paper Series 2023:3, University of Oslo, Health Economics Research Programme.
    8. Fabio Landini & Antonio Nicolò & Marco Piovesan, 2013. "The Hidden Cost of Specialization," IFRO Working Paper 2013/9, University of Copenhagen, Department of Food and Resource Economics.
    9. Andrew J. Epstein & Sean Nicholson & David A. Asch, 2013. "The Production of and Market for New Physicians' Skill," NBER Working Papers 18678, National Bureau of Economic Research, Inc.
    10. Joseph J. Doyle Jr. & Becky Staiger, 2021. "Physician Group Influences on Treatment Intensity and Health: Evidence from Physician Switchers," NBER Working Papers 29613, National Bureau of Economic Research, Inc.

  9. Jonathan Ketcham & Andrew Epstein, 2006. "Which Physicians are Affected Most by Medicaid Preferred Drug Lists for Statins and Antihypertensives?," PharmacoEconomics, Springer, vol. 24(3), pages 27-40, December.

    Cited by:

    1. Alvin Headen, 2006. "Medicaid Preferred Drug Lists: Cost Containment and Side Effects," PharmacoEconomics, Springer, vol. 24(3), pages 1-3, December.

  10. Eisenberg Daniel & Ketcham Jonathan, 2004. "Economic Voting in U.S. Presidential Elections: Who Blames Whom for What," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 4(1), pages 1-25, August.

    Cited by:

    1. Leonardo Martinez, 2008. "A theory of political cycles," Working Paper 05-04, Federal Reserve Bank of Richmond.
    2. Rodrigo Martins & Francisco José Veiga, 2010. "Economic Voting in Portuguese Municipal Elections," NIPE Working Papers 33/2010, NIPE - Universidade do Minho.
    3. Donald J. Lacombe & Timothy M. Shaughnessy, 2007. "Accounting for Spatial Error Correlation in the 2004 Presidential Popular Vote," Public Finance Review, , vol. 35(4), pages 480-499, July.
    4. Jeffrey S. DeSimone & Courtney LaFountain, 2007. "Still the Economy, Stupid: Economic Voting in the 2004 Presidential Election," NBER Working Papers 13549, National Bureau of Economic Research, Inc.
    5. Conconi, Paola & Facchini, Giovanni & Zanardi, Maurizio, 2014. "Policymakers' horizon and trade reforms: The protectionist effect of elections," Journal of International Economics, Elsevier, vol. 94(1), pages 102-118.
    6. Linda Gonçalves Veiga & Francisco José Veiga, 2006. "The impact of local and national economic conditions on legislative election results," NIPE Working Papers 6/2006, NIPE - Universidade do Minho.
    7. Jim Malley & Apostolis Philippopoulos & Ulrich Woitek, 2005. "Electoral Uncertainty, Fiscal Policy and Macroeconomic Fluctuations," CESifo Working Paper Series 1593, CESifo.
    8. José J. Bercoff & Osvaldo Meloni, 2022. "Looking Inside the Ballot Box: Gender Gaps in Argentine Presidential Elections," Working Papers 183, Red Nacional de Investigadores en Economía (RedNIE).
    9. Paola Conconi & Giovanni Facchini & Maurizio Zanardi, 2011. "Policymakers' Horizon and Trade Reforms," Development Working Papers 311, Centro Studi Luca d'Agliano, University of Milano.
    10. Paola Conconi & Nicolas Sahuguet, 2009. "Policymakers' Horizon and the Sustainability of International Cooperation," ULB Institutional Repository 2013/98547, ULB -- Universite Libre de Bruxelles.
    11. Elinder, Mikael, 2010. "Local economies and general elections: The influence of municipal and regional economic conditions on voting in Sweden 1985-2002," European Journal of Political Economy, Elsevier, vol. 26(2), pages 279-292, June.
    12. Sahuguet, Nicolas & Conconi, Paola, 2005. "Re-election Incentives and the Sustainability of International Cooperation," CEPR Discussion Papers 5401, C.E.P.R. Discussion Papers.
    13. Artés, Joaquín, 2014. "The rain in Spain: Turnout and partisan voting in Spanish elections," European Journal of Political Economy, Elsevier, vol. 34(C), pages 126-141.
    14. Burnett, Wesley & Lacombe, Donald J., 2012. "Accounting for Spatial Autocorrelation in the 2004 Presidential Popular Vote: A Reassessment of the Evidence," The Review of Regional Studies, Southern Regional Science Association, vol. 42(1), pages 75-89, Spring.

  11. Danzon Patricia M. & Ketcham Jonathan D., 2004. "Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand," Forum for Health Economics & Policy, De Gruyter, vol. 7(1), pages 1-56, January.
    See citations under working paper version above.

Chapters

  1. Patricia M. Danzon & Jonathan D. Ketcham, 2004. "Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand," NBER Chapters, in: Frontiers in Health Policy Research, Volume 7, pages 1-54, National Bureau of Economic Research, Inc.
    See citations under working paper version above.Sorry, no citations of chapters recorded.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.